Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
156M
-
Shares change
-
-20.3M
-
Total reported value, excl. options
-
$553M
-
Value change
-
-$513M
-
Put/Call ratio
-
0.35
-
Number of buys
-
91
-
Number of sells
-
-44
-
Price
-
$3.54
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q1 2014
185 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q1 2014.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 156M shares
of 274M outstanding shares and own 57.03% of the company stock.
Largest 10 shareholders include FMR LLC (29.2M shares), WELLINGTON MANAGEMENT CO LLP (20.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (19.4M shares), Meditor Group Ltd (17.9M shares), VANGUARD GROUP INC (11M shares), BlackRock Fund Advisors (7.25M shares), State Street Corp (6.07M shares), BlackRock Institutional Trust Company, N.A. (5.51M shares), GOLDMAN SACHS GROUP INC (3.19M shares), and ORBIMED ADVISORS LLC (2.89M shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.